Life sciences are staring at a $1.5T revenue hit—time to rethink the playbook. Suppliers can’t keep doing what worked yesterday. To help the industry navigate headwinds and continue delivering cures, they’ll need new capabilities, new partnerships, and faster execution. In this episode of HFS Unfiltered Stories, Rohan Kulkarni, Executive Research Leader at HFS Research, talks with Paul Watson, Vice President, Global Lead Healthcare & Life Sciences at Hitachi Digital Services, about what it will really take to adapt. They get into:Finding growth in new markets, channels, and engagement modelsRegulatory shifts as more countries run their own approvals (not just the FDA)Speed to value, where partners that can design, build, run, and service plants end-to-end take the leadWatch now for practical insights on where life sciences are headed.: https://www.hfsresearch.com/research/life-sciences-survival-consumers/

Ver todos los episodios